RELMADA THERAPEUTICS, INC.
For the period ended May 27, 2026. Filed Apr 17, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 27, 2026 · Filed Apr 17, 2026
Use the contents to explore the available documents and sections.
Contents
General
The enclosed proxy is solicited on behalf of the Board of Directors (the “Board”) of Relmada Therapeutics, Inc. for use at our 2026 annual meeting of stockholders to be held in a virtual-only (online) meeting format via live webcast on the Internet on May 27, 2026 at 9:30 a.m. Eastern Time. Voting materials, including this proxy statement and proxy card, are expected to be first delivered to all or our stockholders on or about April 17, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.